The MS Society, which in the 1990s had refused to press for access to herbal cannabis, changed its position and called for it to be legalised for medicinal use by people with multiple sclerosis. The cannabis-based spray Sativex was licensed but not available on the health service except in Wales.[1]
Listed for context. No score change is recorded for United Kingdom here.
References
- Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis in the UK, 1973–2004Suzanne Taylor · In Cannabis: Global Histories, edited by Lucas Richert, James H. Mills · MIT Press · 2021 · pp. 356 · ISBN 9780262366137
Checked. The date and the event were compared with a source that was read.